Celldex Therapeutics Inc
CLDX
$37.79-0.26%
Delayed · as of Sep 22, 2026, 10:01 AM ET
Mkt cap
$2.35B
EV/Sales
N/A
P/E ratio
N/A
Revenue (qtr ended 2026-06-30)
$22,000
EPS (H1 2026)
$-2.11
Gross Margin (qtr ended 2026-06-30)
N/A
Profit Margin (qtr ended 2026-06-30)
-334104.55%
Beta
0.98
Div yield
N/A
Sector
Healthcare
Celldex Therapeutics Inc (CLDX) is a biotechnology company listed on US.
Latest reported CLDX revenue for 2026-06-30 was $22.0K. Net income was -$73.5M. Revenue was up 46.7% from 2026-03-31 to 2026-06-30. CLDX currently screens at market cap $2.35B.
Use this CLDX research hub for sector, financials, and filings — not a live tape.
Each line names its own latest cached period. Full CLDX income, balance, and cash tables.
Celldex Therapeutics Inc (CLDX) is a biotechnology company in the Healthcare sector.
Latest cached Celldex Therapeutics Inc (CLDX) revenue for Jun 30, 2026 was $22.0K. Net income was -$73.5M. Statements: https://lician.com/financials/cldx
Celldex Therapeutics Inc (CLDX) market capitalization is $2.35B on the latest cached snapshot.
Celldex Therapeutics Inc (CLDX) cached previous close $37.89; day range $36.41 – $38.00; volume 3,371,687. Session quote: https://lician.com/quote/cldx
Celldex Therapeutics Inc (CLDX) latest cached earnings event is "CLDX earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached CLDX filing is 8-K · Sep 22, 2026. Filings: https://lician.com/sec/cldx